AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation

Clinical trial NCT03005236 · UNKNOWN

Trial details

NCT number: NCT03005236
Sponsor: University Hospital Birmingham NHS Foundation Trust
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Kidney Transplant Failure and Rejection

Start date: 2017-04-01
Primary completion: 2019-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.